Pura Vida Investments

company

About

Pura Vida Investments is a healthcare-focused investment vehicle specialized in private equity investments.

  • 11 - 50

Highlights

Details

Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Pura Vida Investments is a fundamentally driven, market neutral healthcare-focused investment vehicle. The objective of the firm is to identify and capitalize on structural changes in the healthcare landscape and on inflections in company specific valuations. The firm strives to look past day-to-day volatility and to hone in on major value shifts over the medium to longer term.

The firm’s portfolio is managed by Efrem Kamen and Doron Junger MD and is run in a market neutral fashion, investing across most areas of healthcare, including medical devices, biotechnology, pharmaceuticals, tools, life sciences and healthcare services. The Fund has an optional 10% allocation to designated investments, allowing participation in private and certain illiquid public securities, which is managed by Frank Litvack MD.

Investments

Number of Investments
Number of Lead Investments
10
0
Pura Vida Investments has made 10 investments. Their most recent investment was on Feb 3, 2022, when Greenlight Biosciences raised $125.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Equity $125.50M Agriculture
Jan 25, 2022 Metagenomi
Series B $175M Artificial Intelligence
Dec 7, 2021 Freenome
Series D $300M Biotechnology
Oct 7, 2021 Science 37
Post-IPO Equity $200M Biotechnology
Private Equity(PE) $830M Biotechnology